Disclosure of shareholdings – Holta Invest AS (2025)

03. Mar 2025 | 1 min read

3 March 2025

Holta Invest AS has today sold 1,228,502 shares in Gentian Diagnostics ASA and holds after this transaction no longer any shares in Gentian Diagnostics ASA.

Consequently, Holta Invest AS has passed the 5% threshold pursuant to Section 4-2 (1) of the Norwegian Securities Trading Act.

This information is subject to the disclosure requirements pursuant to Section 4-2 and 5-12 of the Norwegian Securities Trading Act

You may also read


May 06, 2026 - Ole Sørlie

Gentian Diagnostics: First quarter 2026 report

Moss, 6 May 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic tests,..

May 06, 2026 - Ole Sørlie

Gentian Diagnostics ASA terminates NT-proBNP assay development

Moss, 6 May 2026 Following a comprehensive review of performance data and market dynamics, Gentian..

May 06, 2026 - Ole Sørlie

Gentian Diagnostics: Ex dividend NOK 0.60 today

Moss, 6 May 2026 The shares in Gentian Diagnostics ASA will be traded ex dividend NOK 0.60 as of today. The..